Pharma: Novartis shares dropped 9% following three setbacks in drug trials, impacting investor confidence and market performance.
Novartis shares took a hit on Tuesday as the results from its del-desiran drug trial fell short of investor expectations. 📉 What does this mean for the future of the company? Stay tuned for updates! #Novartis #PharmaNews
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
